BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3878119)

  • 21. [Adenosine deaminase deficiency and severe combined immunodeficiency].
    Ueland PM
    Tidsskr Nor Laegeforen; 1980 Feb; 100(5):274-6. PubMed ID: 7385150
    [No Abstract]   [Full Text] [Related]  

  • 22. Characteristics of an aminohydrolase distinct from adenosine deaminase in cultured human lymphoblasts.
    Daddona PE; Kelley WN
    Biochim Biophys Acta; 1981 Apr; 658(2):280-90. PubMed ID: 6972784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A phenotypically normal revertant of an adenosine deaminase-deficient lymphoblast cell line.
    Uberti J; Peterson WD; Lightbody JJ; Johnson RM
    J Immunol; 1983 Jun; 130(6):2866-70. PubMed ID: 6854019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adenosine deaminase deficiency in combined immunologic deficiency disease.
    Meuwissen HJ; Pickering RJ; Pollara B
    Birth Defects Orig Artic Ser; 1975; 11(1):117-9. PubMed ID: 1148375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Severe combined immunodeficiency with adenosine deaminase deficiency (author's transl)].
    Allepuz Llop N; Pellejá Pellejá J
    An Esp Pediatr; 1982 May; 16(5):421-5. PubMed ID: 7114620
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cloning of human adenosine deaminase cDNA and expression in mouse cells.
    Valerio D; McIvor RS; Williams SR; Duyvesteyn MG; van Ormondt H; van der Eb AJ; Martin DW
    Gene; 1984 Nov; 31(1-3):147-53. PubMed ID: 6526272
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Primary immunodeficiencies and purine metabolism].
    Romo Cortina A; Lorente Toledano F; Salazar Villalobos V
    Rev Clin Esp; 1985 Oct; 177(6):247-53. PubMed ID: 3001848
    [No Abstract]   [Full Text] [Related]  

  • 28. Adenosine deaminiase: characteristics of the normal and mutant forms of the human enzyme.
    Daddona PE; Kelley WN
    Ciba Found Symp; 1978; (68):177-91. PubMed ID: 387356
    [No Abstract]   [Full Text] [Related]  

  • 29. A high proportion of ADA point mutations associated with a specific alanine-to-valine substitution.
    Markert ML; Norby-Slycord C; Ward FE
    Am J Hum Genet; 1989 Sep; 45(3):354-61. PubMed ID: 2773932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amplification and molecular cloning of murine adenosine deaminase gene sequences.
    Yeung CY; Frayne EG; Al-Ubaidi MR; Hook AG; Ingolia DE; Wright DA; Kellems RE
    J Biol Chem; 1983 Dec; 258(24):15179-85. PubMed ID: 6197412
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of mRNA for adenosine deaminase using biotinylated probes.
    Marshall ME; Riley LK; Coleman MS
    Adv Exp Med Biol; 1986; 195 Pt A():247-52. PubMed ID: 3755278
    [No Abstract]   [Full Text] [Related]  

  • 32. Adenosine deaminase (ADA) and other enzyme abnormalities in immune deficiency states.
    Goldblum RM; Schmalstieg FC; Nelson JA; Mills GC
    Birth Defects Orig Artic Ser; 1978; 14(6A):73-84. PubMed ID: 215243
    [No Abstract]   [Full Text] [Related]  

  • 33. Basic molecular defect in ADA-SCID.
    Herbschleb-Voogt E; Scholten JW; Vossen JM; Pearson PL; Meera Khan P
    Adv Exp Med Biol; 1984; 165 Pt A():381-4. PubMed ID: 6720406
    [No Abstract]   [Full Text] [Related]  

  • 34. A family of adenosine deaminase deficiency with severe combined immunodeficiency.
    Tsuchiya S; Narisawa K; Konno T; Tada K
    Jinrui Idengaku Zasshi; 1979 Jun; 24(2):95-8. PubMed ID: 529554
    [No Abstract]   [Full Text] [Related]  

  • 35. Complete and partial adenosine deaminase deficiency. Relationship of immune function to metabolite concentrations, enzyme activity, and effects of therapy.
    Hirschhorn R
    Ann N Y Acad Sci; 1985; 451():20-5. PubMed ID: 3907453
    [No Abstract]   [Full Text] [Related]  

  • 36. Basic defect in the expression of adenosine deaminase in ADA-SCID disease. II. Deficiency of ADA-CRM detected in heterozygote human-Chinese hamster cell hybrids.
    Herbschleb-Voogt E; Scholten JW; Meera Khan P
    Hum Genet; 1983; 63(2):121-5. PubMed ID: 6840756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adenosine deaminase and immunodeficiency.
    Cohen F
    Birth Defects Orig Artic Ser; 1975; 11(1):124-7. PubMed ID: 1148377
    [No Abstract]   [Full Text] [Related]  

  • 38. [Immunological failure caused by adenosine deaminase deficiency].
    Sylwestrowicz T; Gruchalska E
    Acta Haematol Pol; 1979; 10(3):205-10. PubMed ID: 116467
    [No Abstract]   [Full Text] [Related]  

  • 39. [Familial immune deficit and genetic deficiency of adenosine deaminase or of nucleoside phosphorylase (author's transl)].
    Gajdos A
    Nouv Presse Med; 1978 Mar; 7(11):929-34. PubMed ID: 306093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Establishment and characterization of adenosine deaminase-deficient human T cell lines.
    Kohn DB; Mitsuya H; Ballow M; Selegue JE; Barankiewicz J; Cohen A; Gelfand E; Anderson WF; Blaese RM
    J Immunol; 1989 Jun; 142(11):3971-7. PubMed ID: 2497184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.